Etoposide Injection

Generic name
etoposide
Brand Reference
Vepesid®
Therapeutic Class
antineoplastic agent
Strength
20 mg/mL
DIN
02080036
Product form
Solution for injection


Product Details

Product Code UPC Pack Size
55776281 068510645104 Vial 10 mL
55776181 068510645050 Vial 5 mL
55775481 068510645258 Vial 25 mL
55775581 068510645333 Vial 50 mL

Ingredients

Please view the product monograph to find details of all ingredients contained in this product.  For additional generic & OTC product inquiries, please call 1-800-268-4127, option 3 or email druginfo@tevacanada.com.

Storage

Store between 15°C - 30°C.

Information

All information about raw materials and / or allergen information for Teva Canada’s products is obtained from our suppliers and/or third party affiliates and is based on their records.

Please be advised that the Medical Information department is not always notified of change in third party affiliates and / or change in suppliers of the excipients that may occur over time, and all information provided herein is based on our last current records.

"Latex" – refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process, however this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and / or packaging facilities may be wearing latex gloves